UB Paderborn / Katalog / Suche / in CDI

Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency

European journal of endocrinology, 2016-05, Vol.174 (5), p.601

2016

Link zum Volltext

Verfügbarkeit prüfen

Approach to the Adult with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

The journal of clinical endocrinology and metabolism, 2008-03, Vol.93 (3), p.653-660

Merke, Deborah P

2008

Link zum Volltext

Verfügbarkeit prüfen

Management of adolescents with congenital adrenal hyperplasia

The lancet. Diabetes & endocrinology, 2013-12, Vol.1 (4), p.341-352

2013

Link zum Volltext

Verfügbarkeit prüfen

Modified-Release Hydrocortisone to Provide Circadian Cortisol Profiles

The journal of clinical endocrinology and metabolism, 2009-05, Vol.94 (5), p.1548-1554

2009

Link zum Volltext

Verfügbarkeit prüfen

Pubertal and Gender-Related Changes in the Sympathoadrenal System in Healthy Children

The journal of clinical endocrinology and metabolism, 2002-11, Vol.87 (11), p.5038-5043

2002

Link zum Volltext

Verfügbarkeit prüfen

A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (ChronocortTM) vs. conventional hydrocortisone (CortefTM) in the treatment of congenital adrenal hyperplasia

Clinical endocrinology (Oxford), 2010-04, Vol.72 (4), p.441-447

2010

Link zum Volltext

Verfügbarkeit prüfen

Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers-Danlos contiguous gene deletion syndrome CAH-X

BMC research notes, 2019-10, Vol.12 (1), p.711-711, Article 711

2019

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia

The journal of clinical endocrinology and metabolism, 2021-12, Vol.106 (12), p.e5247-e5257

2021

Link zum Volltext

Verfügbarkeit prüfen

Psychiatric characterization of children with genetic causes of hyperandrogenism

European journal of endocrinology, 2010-11, Vol.163 (5), p.801

2010

Link zum Volltext

Verfügbarkeit prüfen

Adrenomedullary Dysplasia and Hypofunction in Patients with Classic 21-Hydroxylase Deficiency

The New England journal of medicine, 2000-11, Vol.343 (19), p.1362-1368

2000

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal Assessment of Illnesses, Stress Dosing, and Illness Sequelae in Patients With Congenital Adrenal Hyperplasia

The journal of clinical endocrinology and metabolism, 2018-06, Vol.103 (6), p.2336-2345

2018

Link zum Volltext

Verfügbarkeit prüfen

11-Oxygenated Androgens Are Biomarkers of Adrenal Volume and Testicular Adrenal Rest Tumors in 21-Hydroxylase Deficiency

The journal of clinical endocrinology and metabolism, 2017-08, Vol.102 (8), p.2701-2710

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical Characteristics of a Cohort of 244 Patients with Congenital Adrenal Hyperplasia

The journal of clinical endocrinology and metabolism, 2012-12, Vol.97 (12), p.4429-4438

2012

Link zum Volltext

Verfügbarkeit prüfen

An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure

Clinical endocrinology (Oxford), 2014-04, Vol.80 (4), p.554-561

2014

Link zum Volltext

Verfügbarkeit prüfen

A Phase 2 Study of Chronocort, a Modified-Release Formulation of Hydrocortisone, in the Treatment of Adults With Classic Congenital Adrenal Hyperplasia

The journal of clinical endocrinology and metabolism, 2015-03, Vol.100 (3), p.1137-1145

2015

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive Genetic Analysis of 182 Unrelated Families with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

The journal of clinical endocrinology and metabolism, 2011-01, Vol.96 (1), p.E161-E172

2011

Link zum Volltext

Verfügbarkeit prüfen

Androgen excess and diagnostic steroid biomarkers for nonclassic 21-hydroxylase deficiency without cosyntropin stimulation

European journal of endocrinology, 2020-07, Vol.183 (1), p.63

2020

Link zum Volltext

Verfügbarkeit prüfen

Complement component 4 variations may influence psychopathology risk in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Human genetics, 2018-12, Vol.137 (11-12), p.955-960

2018

Link zum Volltext

Verfügbarkeit prüfen

Modified release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia

The journal of clinical endocrinology and metabolism, 2017-06, Vol.102 (6), p.1797-1806

2017

Link zum Volltext

Verfügbarkeit prüfen

A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia

The journal of clinical endocrinology and metabolism, 2020-08, Vol.105 (8), p.2771-2778

2020

Link zum Volltext

Verfügbarkeit prüfen

Adrenal morphology and associated comorbidities in congenital adrenal hyperplasia

Clinical endocrinology (Oxford), 2019-08, Vol.91 (2), p.247-255

2019

Link zum Volltext

Verfügbarkeit prüfen

Ehlers-Danlos Syndrome Caused by Biallelic TNXB Variants in Patients with Congenital Adrenal Hyperplasia

Human mutation, 2016-09, Vol.37 (9), p.893-897

2016

Link zum Volltext

Verfügbarkeit prüfen

Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia

The journal of clinical endocrinology and metabolism, 2015-08, Vol.100 (8), p.E1143-E1152

2015

Link zum Volltext

Verfügbarkeit prüfen

Tenascin-X Haploinsufficiency Associated with Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia

The journal of clinical endocrinology and metabolism, 2013-02, Vol.98 (2), p.E379-E387

2013

Link zum Volltext

Verfügbarkeit prüfen

Patients with Classic Congenital Adrenal Hyperplasia Have Decreased Epinephrine Reserve and Defective Glucose Elevation in Response to High-Intensity Exercise

The journal of clinical endocrinology and metabolism, 2004-02, Vol.89 (2), p.591-597

2004

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency

Approach to the Adult with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

Management of adolescents with congenital adrenal hyperplasia

Modified-Release Hydrocortisone to Provide Circadian Cortisol Profiles

Pubertal and Gender-Related Changes in the Sympathoadrenal System in Healthy Children

A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (ChronocortTM) vs. conventional hydrocortisone (CortefTM) in the treatment of congenital adrenal hyperplasia

Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers-Danlos contiguous gene deletion syndrome CAH-X

Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia

Psychiatric characterization of children with genetic causes of hyperandrogenism

Adrenomedullary Dysplasia and Hypofunction in Patients with Classic 21-Hydroxylase Deficiency

Longitudinal Assessment of Illnesses, Stress Dosing, and Illness Sequelae in Patients With Congenital Adrenal Hyperplasia

11-Oxygenated Androgens Are Biomarkers of Adrenal Volume and Testicular Adrenal Rest Tumors in 21-Hydroxylase Deficiency

Clinical Characteristics of a Cohort of 244 Patients with Congenital Adrenal Hyperplasia

An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure

A Phase 2 Study of Chronocort, a Modified-Release Formulation of Hydrocortisone, in the Treatment of Adults With Classic Congenital Adrenal Hyperplasia

Comprehensive Genetic Analysis of 182 Unrelated Families with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

Androgen excess and diagnostic steroid biomarkers for nonclassic 21-hydroxylase deficiency without cosyntropin stimulation

Complement component 4 variations may influence psychopathology risk in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Modified release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia

A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia

Adrenal morphology and associated comorbidities in congenital adrenal hyperplasia

Ehlers-Danlos Syndrome Caused by Biallelic TNXB Variants in Patients with Congenital Adrenal Hyperplasia

Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia

Tenascin-X Haploinsufficiency Associated with Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia

Patients with Classic Congenital Adrenal Hyperplasia Have Decreased Epinephrine Reserve and Defective Glucose Elevation in Response to High-Intensity Exercise

Aktive Filter

Suchergebnisse filtern